Faecal microbiota transplantation: a potential novel therapeutic avenue for Duchenne muscular dystrophy

被引：0
|
作者：
Timpani, C. [1 ,2 ,3 ]
Debrincat, D. [1 ]
Van der Beek, J. [1 ]
Eri, R. [4 ,5 ]
Diwakarla, S. [3 ,6 ]
McQuade, R. [2 ,3 ,6 ]
Rybalka, E. [1 ,2 ,3 ]
机构：
[1] Victoria Univ, Inst Hlth & Sport, Melbourne, Vic, Australia
[2] Australian Inst Musculoskeletal Sci, St Albans, Australia
[3] Univ Melbourne, Dept Med, Western Hlth, Melbourne Med Sch, St Albans, Australia
[4] Univ Tasmania, Sch Hlth Sci, Launceston, Tas, Australia
[5] RMIT Univ, Sch Sci, STEM Coll, Melbourne, Vic, Australia
[6] Univ Melbourne, Dept Anat & Physiol, Gut Barrier & Dis Lab, Melbourne, Vic, Australia
来源：
NEUROMUSCULAR DISORDERS | 2024年 / 43卷
关键词：
D O I：
10.1016/j.nmd.2024.07.282
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
402P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Genetic Therapeutic Approaches for Duchenne Muscular Dystrophy
    Foster, Helen
    Popplewell, Linda
    Dickson, George
    HUMAN GENE THERAPY, 2012, 23 (07) : 676 - 687
  • [32] THERAPEUTIC TARGETS FOR DUCHENNE MUSCULAR DYSTROPHY (DMD)
    Brown, A. E.
    Sorbera, L. A.
    DRUGS OF THE FUTURE, 2013, 38 (06) : 395 - 406
  • [33] MYOBLASTS TRANSPLANTATION IN DUCHENNE MUSCULAR-DYSTROPHY
    LABRECQUE, C
    BOUCHARD, JP
    MALOUIN, F
    ROY, R
    HUARD, J
    TREMBLAY, JP
    M S-MEDECINE SCIENCES, 1991, 7 (08): : 821 - 829
  • [34] Cardiac transplantation in a Duchenne muscular dystrophy carrier
    Melacini, P
    Fanin, M
    Angelini, A
    Pegoraro, E
    Livi, U
    Danieli, GA
    Hoffman, EP
    Thiene, G
    Dalla Volta, S
    Angelini, C
    NEUROMUSCULAR DISORDERS, 1998, 8 (08) : 585 - 590
  • [35] A state-of-the-art review of tamoxifen as a potential therapeutic for duchenne muscular dystrophy
    Botti, Valeria
    Menzel, Olivier
    Staedler, Davide
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [36] Circadian Clock in Muscle Disease Etiology and Therapeutic Potential for Duchenne Muscular Dystrophy
    Kiperman, Tali
    Ma, Ke
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (09)
  • [37] Evaluating the potential of novel genetic approaches for the treatment of Duchenne muscular dystrophy
    Himic, Vratko
    Davies, Kay E.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2021, 29 (09) : 1369 - 1376
  • [38] Evaluating the potential of novel genetic approaches for the treatment of Duchenne muscular dystrophy
    Vratko Himič
    Kay E. Davies
    European Journal of Human Genetics, 2021, 29 : 1369 - 1376
  • [39] EXPLORING NOVEL THERAPEUTIC CHEMISTRIES IN EXON-SKIPPING FOR DUCHENNE MUSCULAR DYSTROPHY
    Bao, L. T.
    Herdewijn, P.
    Filichev, V. V.
    Wilton, S. D.
    Fletcher, S.
    Veedu, R. N.
    JOURNAL OF GENE MEDICINE, 2018, 20 (01):
  • [40] Cardiovascular Disease in Duchenne Muscular Dystrophy Overview and Insight Into Novel Therapeutic Targets
    Schultz, Taylor, I
    Raucci, Frank J., Jr.
    Salloum, Fadi N.
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2022, 7 (06): : 608 - 625
12345